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A B S T R A C T
BK and JC polyomavirus infections are acquired commonly during childhood, mainly asymptomat-
ically. These viruses are thought to remain latent in renal tissue after the primary infection and to
reactivate under certain conditions. This reactivation leads to urinary excretion of virus particles, which
can be detected by a range of methods. However, while this reactivation has been studied in depth in
immunocompromised patients, little information is available about healthy individuals. The present
study used PCR-based methods to examine urine samples from healthy individuals (51 adults and
15 children), and found that 62.7% of adults and 13.2% of children excreted polyomaviruses in the
urine, mostly JC virus (41.2%). JC virus excretion was continuous, while BK virus excretion was mostly
occasional.
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I N T R O D U C T I O N
Human JC and BK polyomaviruses are naked DNA
viruses with a 5-kb double-stranded, circular,
super-coiled genome that are now classified within
the Polyomaviridae family. Serological surveys
have shown that these viruses are ubiquitous in the
human population, with type-specific antibodies
detectable in c. 60–80% of healthy adults [1].
Primary BK virus (BKV) infection occurs in early
childhood, and primary JC virus (JCV) infection in
late childhood. After primary infection, both vir-
uses persist in renal tissue, and probably also in
B-lymphocytes and other locations [2,3]. Primary
human polyomavirus (HPyV) infections are gen-
erally asymptomatic, and no definite clinical
presentations have been attributed conclusively
to HpyVs, although fever and non-specific upper
respiratory symptoms have been suggested [4].
However, reactivation of these viruses in immu-
nocompromised patients with relative or absolute
cellular immunodeficiency has been associated
clearly with serious complications [5]. JCV is
neurotropic, and reactivation produces progres-
sive multifocal leucoencephalopathy (a fatal
demyelinating neurological disease) in individuals
with immunological deficits such as AIDS, and in
cancer patients or transplant recipients [6]. BKV
reactivation is associated with interstitial nephritis
[7] and ureteral stenosis in renal allograft recipi-
ents, and late onset haemorrhagic cystitis in bone
marrow transplant patients [5].
Reactivation of HPyVs may also occur in
otherwise healthy people, leading to asympto-
matic viruria [8,9]. As a consequence, urban
sewage frequently becomes contaminated and
yields high viral titres [10]. Many questions
concerning the pathogenesis and natural history
of infection remain unanswered. It is likely that,
because of their ubiquity, HPyVs may be trans-
mitted by means of direct or indirect exposure to
bodily fluids, such as excreta or other secretions,
probably via oral, respiratory, transplacental and
perinatal routes [4]. However, little is known
about the prevalence and temporal pattern of
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urinary excretion in healthy individuals. Com-
parative studies with healthy individuals and
patients may clarify the relationship between
asymptomatic excretion and the development of
disease. The present study focuses on this issue
by analysing urine samples from healthy individ-
uals (adults and children).
M A T E R I A L S A N D M E T H O D S
Clinical specimens
In total, 280 urine samples were obtained from healthy
individuals (51 adults aged 25–57 years, and 15 children aged
3–13 years). None were taking drugs that might influence the
urinary excretion, and no female was pregnant during the
study period. Samples were taken from all patients at baseline.
In 28 ⁄ 51 adults and 9 ⁄ 15 children, an additional follow-up was
performed, with urine samples obtained after 7 and 15 days,
and after 1, 3 and 6 months. Specimens were stored at )70 C
until processed.
DNA extraction
Nucleic acids were extracted from urine samples with a
thiocyanate-based method [11] in which 50 lL of urine was
mixed with 200 lL of lysis buffer comprising 160 lL 5 M
guanidine thiocyanate, 5 lL 1 M sodium citrate pH 7.0,
0.2 lL 1 M dithiotreitol, 33.3 lL sarcosyl 3% w ⁄v, 1 lL glyco-
gen 20 mg ⁄mL, and 0.5 lL distilled water. After incubation of
this mix for 10 min, 250 lL isopropanol was added to each
tube and the samples were centrifuged for 10 min at 13 000 g.
The supernatants were discarded and the pellets washed with
500 lL ethanol 70% v ⁄v. After a second centrifugation step,
the ethanol was discarded and the pellets were dissolved in
10 lL distilled water. DNA extracts were stored at ) 70 C
until required for PCR.
PCR detection
Detection of BKV and JCV was carried out with a multiplex
hemi-nested PCR and degenerate primers [12] which ampli-
fied a specific region of the T-large antigen, common for BKV,
JCV and the human polyomavirus-related simian virus 40
(SV40). First round external PCR mixes contained 5 lL 10·
PCR buffer (Roche, Barcelona, Spain), 8 lL 25 mM MgCl2,
0.4 lL 25 mM dNTP mix, 0.2 lL (0.2 pmol) PM1+ primer,
0.2 lL (0.2 pmol) PM1– primer (Table 1), 0.5 lL (2.5 U) Taq
polymerase (Roche), 30.7 lL distilled water and 5 lL DNA
extract. Amplification conditions were as follows: 94 C for
7 min; 40 cycles of 94 C for 30 s, 61 C for 1 min, and 72 C
for 30 s; and a final extension period at 72 C for 5 min.
Second-round internal PCR mixes contained 5 lL 10· PCR
buffer, 4 lL 25 mM MgCl2, 0.4 lL 25 mM dNTP mix, 0.1 lL
(0.1 pmol) JC+ primer, 0.1 lL (0.1 pmol) BKV+ primer, 0.1 lL
(0.1 pmol) SV40+ primer, 0.1 lL (0.1 pmol) PM2– primer
(Table 1), 0.4 lL (2 U) Taq polymerase, 38.8 lL distilled water
and 1 lL of first-round PCR product. Second-round amplifi-
cation conditions were as follows: 94 C for 7 min; 30 cycles of
94 C for 30 s, 55 C for 1 min, and 72 C for 30 s; and a final
extension period at 72 C for 5 min. A negative control
(distilled water instead of urine) was included in each batch
of reactions (extraction and amplification). As a positive
control, a mixture of plasmids with JCV, BKV and SV40
T-large inserts were used (Centro Nacional de Microbiologı´a,
Madrid, Spain). Final PCR products were analysed by electro-
phoresis on agarose 1.5% w ⁄v gels, followed by staining with
ethidium bromide. A positive result was indicated by bands of
353 bp, 189 bp and 135 bp in the stained gels for BKV, JCV and
SV40, respectively.
Analytical sensitivity of the procedure
Before testing the urine samples, the sensitivity of the complete
procedure was calculated by amplifying serial dilutions of the
individual plasmids in 50 lL of distilled water. Conditions for
extraction and amplification were the same as for the clinical
samples, and all dilutions were assayed in triplicate.
Possible inhibitory effect of urine on nucleic acid
amplification
The potential inhibitory effect of substances present in urine was
investigated by amplifying 14 urine samples negative for HPyV
that were spiked with 100 copies of a competitive internal
standard with a heterologous sequence containing the four
primers used for PCR (Table 1), except for primers JC+, BK+ and
SV+, which were replaced by PM2+ [13]. Conditions for PCR
amplification were as described above. In the absence of any
inhibition, a 183-bp band amplification product was visualised.
R E S U L T S
Assay validation
When the analytical sensitivity was calculated,
BKV and SV40 sequences were detected at con-
centrations ranging from two to ten copies ⁄ 50 lL.
The amplification procedure was less efficient for
JCV, which was detected at a concentration of
ten copies ⁄ 50 lL. No inhibitory effect of urine
on PCR amplification was observed, and all
HPyV-negative samples spiked with the internal
standard gave the expected 183-bp band.
Prevalence study
The results of the prevelance study are shown in
Table 2. At baseline, 32 (62.7%) of 51 adults
Table 1. Primers used for the hemi-nested PCR amplifi-
cation
Primer Sequence
PM1+ 5¢-TCY TCT GGN NTA AAR TCA TGT TCC-3¢
PM1– 5¢-TTW TAG RTK CCA ACC TAT GGA AC-3¢
JC+ 5¢-ATA TTA TGA CCM CCA AAA CCA TG-3¢
BK+ 5¢-GAA TGC TTT CTT CTA TAG TAT GGT ATG-3¢
SV+ 5¢-ATA ATT TTT TTG TAT AGC AGT GCA-3¢
PM2– 5¢-GGT AGA AGA CCC YAA RGA CTT TCC-3¢
PM2+ 5¢-GCW GAM ACT CTA TGY CTR TGT GG-3¢
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analysed excreted at least one type of HPyV in
urine. Of these, 21 (41.2%) excreted JCV, eight
(15.7%) BKV, and three (5.9%) both JCV and BKV.
Only two children were HPyV excreters, one JCV
and one BKV. In addition, five and seven adults
with negative results at baseline were positive for
JCV and BKV, respectively, during follow-up. Two
other children with BKV, but not JCV, were
identified in sequential samples (see below).
Although most of the individuals had been
vaccinated against poliovirus (after 1961), none of
the urine samples analysed, either at baseline or
in the follow-up, was positive for SV40 virus.
Analysis of the urinary excretion pattern
After baseline determinations, 28 adults and nine
children were followed up for 6 months (Fig. 1).
Table 2. Prevalence of urinary
polyomavirus excretion in healthy
individuals
Number (%) of persons excreting HPyVs in urine at baseline
JCV BKV Both JCV and BKV SV40 Any type of HPyV
Adults (n ¼ 51) 21 (41.2) 8 (15.7) 3 (5.9) 0 32 (62.7)
Children (n ¼ 15) 1 (6.6) 1 (6.6) 0 0 2 (13.2)
HpyVs, human polyomaviruses; BKV, BK virus; JCV, JC virus; SV40, simian virus 40.
Fig. 1. Urinary excretion pattern in
healthy individuals. JCV, JC virus;
BKV, BK virus; BL, baseline; Ad,
adult; Ch, child; ND, not done.
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Four excretion patterns were defined: occasional
excreters, i.e., individuals with only one positive
sample throughout the follow-up period; short-
term excreters, with two or three of the six
specimens positive within 15 days; long-term
excreters, with between two and four positive
samples separated by at least 15 days; and con-
tinuous excreters, with five or six positive sam-
ples during the follow-up period.
As shown in Fig. 1, 23 of 28 adults, and four of
nine children, excreted HPyVs at some point. For
JCV, the pattern was continuous in 50.0%, long-
term in 21.4%, and occasional in 3.6% of adults.
In contrast, for BKV, the pattern was occasional in
21.4%, long-term in 14.3%, short-term in 3.6%,
and continuous in none of the adults. Among the
children, one was a continuous excreter of JCV
and a long-term excreter of BKV, two were
occasional excreters of BKV, and one was a
long-term excreter of BKV (Table 3).
D I S C U S S I O N
The human polyomaviruses BKV and JCV are the
most prevalent viruses of this type worldwide.
With the exception of closed population groups,
such as rainforest tribes in which HPyVs have not
evolved, > 70% of adults show a specific antibody
response to these viruses, and these figures for
seroprevalence are quite similar in different geo-
graphical areas [4]. After seroconversion follow-
ing primary infection (which occurs earlier with
BKV than with JCV), these viruses persist in the
host, mainly in renal tissue and the urinary tract,
where they replicate eventually and are excreted
in urine. Until recently, urinary excretion was
believed to be restricted to certain states of slight
immunosuppression (such as pregnancy) or,
more frequently, to severely immunocompro-
mised hosts (e.g., AIDS patients and transplant
recipients) [6]. With the advent of more sensitive
analytical methods, recent studies have demon-
strated that replication also occurs throughout
adult life in normal subjects [14,15].
In the present study, high percentages of
urinary excretion were found in the adult popu-
lation investigated, especially for JCV. In addi-
tion, 5.9% of adults excreted both HPyVs
simultaneously. These percentages of replication
for JCV are similar to those obtained in recent
studies with immunocompetent subjects [14,16],
and are clearly higher than those described in
early surveys [9,17]. Such differences may be
associated with the more sensitive amplification
techniques used (i.e., nested PCR). Also, most of
the adults screened were aged > 30 years, at
which age the prevalence of urinary excretion, at
least for JC virus, increases clearly [16]. Moreover,
the fact that some subjects were identified as
HPyV excreters in the follow-up, but not at
baseline, suggests that the percentage of healthy
people with persistent urinary excretion may be
underestimated. However, it should be noted that
an internal control to check the absence of the
inhibitory effect of individual urine samples was
not used systematically, although the assay val-
idation showed no such effect in 14 specimens.
Overall, this high prevalence of urinary excretion
was consistent with recent results showing that
HPyVs are detected frequently at high titres in a
high proportion of urban sewage samples from
different locations around the world [10,18].
Therefore, it can be assumed that urban residents
may be exposed increasingly to these viruses.
Interestingly, SV40, a polyomavirus which causes
neoplasms in non-human primates and which
contaminated batches of cell cultures used for the
production of polio vaccines before 1961, was not
detected, either in environmental samples or in
urine from healthy subjects, suggesting that this
virus does not circulate among the human pop-
ulation.
In children, the overall frequency of excretion
was clearly lower than in adults, but the propor-
tion of BKV and JCV excreters was similar in the
present study. These results were consistent with
data from serological surveys showing that BKV
infection is acquired earlier than JCV infection,
and also with PCR-based studies of urinary
excretion which reported a marked increase in
JCV viruria above the age of 30 years [16].
The results of this prospective follow-up study
show that the pattern of excretion for JCV is
Table 3. Summary of excretion patterns of human poly-
omaviruses in healthy individuals
Number (%) of subjects showing pattern of excretion
Continuous Long-term Short-term Occasional
Adults (n ¼ 28)
JCV 14 (50.0) 6 (21.4) 0 1 (3.6)
BKV 0 4 (14.3) 1 (3.6) 6 (21.4)
Children (n ¼ 9)
JCV 1 0 0 0
BKV 0 2 0 2
JCV, JC virus; BKV, BK virus.
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different from that of BKV. Individuals with JCV
present mostly with a continuous pattern of
excretion, with many positive samples during
the follow-up period. In contrast, BKV is excreted
in an occasional manner, both in adults and in
children. Few such experiments have been repor-
ted in the literature, but one study [15] detected
the same JCV genotype in urine samples obtained
at intervals of 5–7 years. These data suggest con-
tinuous viral replication in the urinary tract of a
strain acquired in childhood, rather than repeated
infections with different strains. This continuous
excretion may be necessary for JCV transmission
within the human population, probably by the oral
route, because infection with archetypal JCV
strains (the strains present in urine and sewage)
[19] is clearly inefficient, as shown by recent
in-vitro studies with cell cultures. As for BKV, the
differences in the frequency, and above all in the
pattern, of excretion suggest that there may be
additional mechanisms of transmission other than
the oral route; indeed, transplacental and perinatal
transmission have been postulated [20].
In conclusion, urinary excretion of the HPyVs is
common in healthy subjects. JCV viruria is more
prevalent than BKV, especially in the adult
population. Excreters of JCV in urine show a
continuous time pattern, while BKV excreters are
mainly occasional. These data suggest different
replication and reactivation behaviour for these
viruses and, along with other studies with
HPyVs, have implications with regard to their
transmission and pathogenesis. Many questions
remain unanswered, and further studies of their
epidemiology, natural history and pathogenesis
are required to complete the HPyV puzzle.
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